Primary splenic angiosarcoma presenting with multiple bone destruction as the initial manifestation: a case report and narrative review - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Initial Presentation of Primary Splenic Angiosarcoma with Multiple Bone Lesions: A Case Study and Literature Review

  • By

  • Weijun Wang

  • Xia Liu

  • August 21, 2026

Share

  • 1

    Primary splenic angiosarcoma (PSA) is a rare and aggressive malignant vascular neoplasm with a median survival of 5–12 months.

  • 2

    Initial presentation of PSA with osseous metastasis is uncommon and can lead to diagnostic confusion with other malignancies.

  • 3

    Histological differentiation in angiosarcoma does not always correlate with biological behavior, as well-differentiated tumors can be highly aggressive.

  • 4

    Biopsy of vascular tumors like angiosarcoma carries a significant risk of hemorrhage, necessitating careful pre-procedural assessment.

  • 5

    Accurate diagnosis of PSA requires integration of clinical, imaging, and pathological findings due to its nonspecific manifestations.

Original Source(s)

Primary splenic angiosarcoma presenting with multiple bone destruction as the initial manifestation: a case report and narrative review

  • by Weijun Wang, Xia Liu

  • August 21, 2026

Related Content

Updated ASTRO Guideline Reflects a New Era for Radiation Therapy in Pancreatic Cancer

An updated clinical practice guideline from the American Society for Radiation Oncology substantially expands and modernizes recommendations for the use of radiation therapy in pancreatic cancer.

  • by

  • August 14, 2026

  • 6 min
Moving Cancer Survivorship Into Routine Care—Why Are We Still Not Ready for Change?

Correction: Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer